WHITTIER TRUST CO OF NEVADA INC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 180 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
WHITTIER TRUST CO OF NEVADA INC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$2,494
-22.8%
700.0%0.00%
Q2 2023$3,229
+15.1%
700.0%0.00%
Q1 2023$2,806
-13.4%
700.0%0.00%
Q4 2022$3,242
+8.1%
700.0%0.00%
Q3 2022$3,000
-25.0%
700.0%0.00%
Q2 2022$4,000
-20.0%
700.0%0.00%
Q1 2022$5,000
-16.7%
700.0%0.00%
Q4 2021$6,0000.0%700.0%0.00%
Q3 2021$6,000
-14.3%
700.0%0.00%
Q2 2021$7,000
-12.5%
700.0%0.00%
Q1 2021$8,000
-20.0%
700.0%0.00%
-100.0%
Q4 2020$10,000
+66.7%
700.0%0.00%
Q3 2020$6,000
+20.0%
700.0%0.00%
Q2 2020$5,000
+66.7%
700.0%0.00%
Q1 2020$3,0000.0%700.0%0.00%
Q4 2019$3,0000.0%700.0%0.00%
Q3 2019$3,000
-25.0%
700.0%0.00%
Q2 2019$4,000
-20.0%
700.0%0.00%
Q1 2019$5,000
+66.7%
700.0%0.00%
Q4 2018$3,000
-40.0%
700.0%0.00%
Q3 2018$5,000
-54.5%
70
-50.0%
0.00%
-100.0%
Q2 2018$11,000
+57.1%
1400.0%0.00%0.0%
Q1 2018$7,000
+16.7%
1400.0%0.00%0.0%
Q4 2017$6,000
-14.3%
1400.0%0.00%0.0%
Q3 2017$7,000
-22.2%
1400.0%0.00%0.0%
Q2 2017$9,0001400.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2019
NameSharesValueWeighting ↓
Abingworth LLP 38,100$2,928,0001.67%
Opaleye Management Inc. 80,000$6,149,0001.59%
HIGHLINE CAPITAL MANAGEMENT, L.P. 410,000$31,517,0001.06%
Opus Point Partners Management, LLC 6,311$485,0001.05%
SECTOR GAMMA AS 68,015$5,228,0000.87%
Capital Impact Advisors, LLC 27,074$2,061,0000.76%
FORTALEZA ASSET MANAGEMENT INC/ 1,130$87,0000.71%
CAPITAL INTERNATIONAL LTD /CA/ 46,957$3,610,0000.63%
Virtus ETF Advisers LLC 8,794$676,0000.60%
Rock Springs Capital Management LP 200,000$15,374,0000.59%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders